OpenEvidence raises $200M at $6B valuation for ChatGPT-style medical AI
OpenEvidence, the fast-growing AI platform described as “ChatGPT for doctors,” has raised $200 million at a $6 billion valuation, according to The New York Times — doubling its worth in just three months and underscoring investor confidence in specialized, domain-specific AI.
